A detailed history of Cassia Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cassia Capital Partners, LLC holds 7,563 shares of MRK stock, worth $741,552. This represents 0.57% of its overall portfolio holdings.

Number of Shares
7,563
Previous 7,878 4.0%
Holding current value
$741,552
Previous $975,000 12.0%
% of portfolio
0.57%
Previous 0.64%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$111.15 - $128.97 $35,012 - $40,625
-315 Reduced 4.0%
7,563 $858,000
Q2 2024

Jul 19, 2024

SELL
$123.8 - $132.96 $87,279 - $93,736
-705 Reduced 8.21%
7,878 $975,000
Q1 2024

Apr 22, 2024

BUY
$113.24 - $131.95 $123,091 - $143,429
1,087 Added 14.5%
8,583 $1.13 Million
Q4 2023

Jan 29, 2024

BUY
$100.18 - $109.02 $27,349 - $29,762
273 Added 3.78%
7,496 $817,000
Q3 2023

Oct 16, 2023

BUY
$102.95 - $114.33 $10,500 - $11,661
102 Added 1.43%
7,223 $743,000
Q2 2023

Jul 20, 2023

BUY
$108.61 - $118.38 $121,534 - $132,467
1,119 Added 18.64%
7,121 $821,000
Q1 2023

Apr 21, 2023

SELL
$102.94 - $114.86 $8,132 - $9,073
-79 Reduced 1.3%
6,002 $638,000
Q4 2022

Jan 25, 2023

BUY
$87.44 - $112.11 $152,058 - $194,959
1,739 Added 40.05%
6,081 $0
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $94,504 - $106,165
-1,118 Reduced 20.48%
4,342 $374,000
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $2,504 - $2,839
30 Added 0.55%
5,460 $498,000
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $7,865 - $8,816
107 Added 2.01%
5,430 $446,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $384,746 - $481,944
5,323 New
5,323 $408,000
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $217,405 - $239,091
-3,033 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $213,250 - $235,876
3,033 New
3,033 $236,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cassia Capital Partners, LLC Portfolio

Follow Cassia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cassia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cassia Capital Partners, LLC with notifications on news.